Dose reduction of the new generation biologics (1L17 and lL23 inhibitors) in psoriasis: A pragmatic, multicentre, randomized, controlled, non-inferiority study - BeNeBio study

Referenties

• Dose reduction of the new generation biologics (IL17 and IL23 inhibitors) in psoriasis: A pragmatic, multicentre, randomized, controlled, non-inferiority study (BeNeBio study) - ZonMw

  

  www.zonmw.nl

• Home - BeNeBio

  

  benebio.info